<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02358551</url>
  </required_header>
  <id_info>
    <org_study_id>CJFH-2014-086</org_study_id>
    <nct_id>NCT02358551</nct_id>
  </id_info>
  <brief_title>Comparison of Axillary Vein Puncture With Subclavian Vein Puncture in Pacemaker Implantation</brief_title>
  <official_title>Comparison of Axillary Vein Puncture With Subclavian Vein Puncture in Pacemaker Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China-Japan Friendship Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intrathoracic subclavian venous technique for pacemaker implantation may be associated
      with serious complications. Axillary vein puncture tends to reduce lead implantation
      complications such as pneumothorax and lead crush, but clinical adoption is not widely
      acknowledged, especially in China, although this approach has been proposed for 20 years. The
      major concern is the learning curve for axillary vein puncture and its success rate. The
      investigators try to prove that the success rate of axillary vein puncture is non-inferior to
      subclavian vein puncture, hence to promote the clinical application of axillary vein puncture
      to reduce pacemaker implantation complications.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of vein puncture</measure>
    <time_frame>1 Day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical complication of electrode lead (combined endpoints of hemothorax, pneumothorax, air embolism, inadvertent arterial puncture, hematoma, fracture of electrode lead, nerve injury and subclavian crush syndrome)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of pacemaker implantation</measure>
    <time_frame>1 Day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Mechanical Complication of Cardiac Pacemaker</condition>
  <arm_group>
    <arm_group_label>Axillary vein</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lead Placement Through the Axillary Vein Technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subclaivan vein</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lead Placement Through the Subclavian Vein Technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placement of electrode lead through axillary vein puncture</intervention_name>
    <arm_group_label>Axillary vein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placement of electrode lead through subclavian vein puncture</intervention_name>
    <arm_group_label>Subclaivan vein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with indication of pacemaker or ICD implantation

          -  Personally signed and dated informed consent document

        Exclusion Criteria:

          -  Accompanied with malignant disease or other disease, which cause life expectancy &lt; 1
             year.

          -  Anatomical variation of axillary vein or subclavian vein, unable to puncture.

          -  Poor compliance for follow-up.

          -  Patients with any condition which, in the investigator's judgment, not suitable for
             enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xianlun Li, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>China-Japan Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xianlun Li, MD</last_name>
    <phone>86-10-84206151</phone>
    <email>leexianlun@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peng Liu, MD, PhD</last_name>
    <phone>86-10-84205136</phone>
    <email>liupengdoc@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chen Wang, MD</last_name>
      <phone>86-10-84205566</phone>
      <email>zryyyb@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2015</study_first_submitted>
  <study_first_submitted_qc>February 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2015</study_first_posted>
  <last_update_submitted>February 3, 2015</last_update_submitted>
  <last_update_submitted_qc>February 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China-Japan Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Xianlun Li</investigator_full_name>
    <investigator_title>Deputy Director, Department of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Pacemaker</keyword>
  <keyword>Axillary Vein</keyword>
  <keyword>Subclavian vein</keyword>
  <keyword>Clinical Study</keyword>
  <keyword>Cardiovascular implantable electronic devices</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

